Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer-Reference-Cited by-同舟云学术

Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer

Published:2020-10 Issue:4 Volume:38 Page:567-583.e11
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Gabitova-Cornell Linara,Surumbayeva Aizhan,Peri Suraj,Franco-Barraza Janusz^ORCID,Restifo Diana^ORCID,Weitz Nicole,Ogier Charline^ORCID,Goldman Aaron R.^ORCID,Hartman Tiffiney R.,Francescone Ralph,Tan Yinfei^ORCID,Nicolas Emmanuelle,Shah Neelima,Handorf Elizabeth A.,Cai Kathy Q.,O'Reilly Alana M.,Sloma Ido,Chiaverelli Rachel,Moffitt Richard A.^ORCID,Khazak Vladimir,Fang Carolyn Y.^ORCID,Golemis Erica A.^ORCID,Cukierman Edna^ORCID,Astsaturov Igor^ORCID

Funder

U.S. Department of Defense

Pew Charitable Trusts

Pancreatic Cancer Action Network

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference81 articles.

1. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs;Adams;J. Biol. Chem.,2004

2. Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer;Adams;Elife,2019